Drugs / Atenas
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05144360 | Aug 2022 → Jul 2024 | hypertensive disorder, type 2 diabetes mellitus | EMS | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Atenas | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05144360 ↗ |
| Route | Oral | “1 tablet Atenas, oral” NCT05144360 ↗ |